Clinical Trial Update: Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) [Phase 4]

View source ↗

Summary

Phase 4 randomized trial investigating whether influenza vaccination reduces adverse vascular events in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: McMaster University | Conditions: Heart Failure, Influenza | Phase 4 | Status: UNKNOWN